Contemporary OB/GYN

FDA approves pritelivir tablets to treat lesions from HSV

The FDA has approved pritelivir (Hovilpri) tablets for adults with weakened immune systems who have mucocutaneous lesions ...
Contemporary OB/GYN

Real-world data link fezolinetant to fewer nighttime awakenings

Fezolinetant (Veozah) was associated with statistically significant improvements in objective and patient-reported sleep ...
Contemporary OB/GYN

HPV vaccine before pregnancy tied to fewer adverse pregnancy outcomes

HPV vaccination before pregnancy was linked to lower preterm birth risk. Benefits were greater in women vaccinated at younger ages. The findings suggest HPV vaccination may help beyond cancer ...
Contemporary OB/GYN

Wen Shen, MD, on screening red flags during perimenopause care

Wen Shen, MD, outlines when to treat perimenopausal symptoms and which history-taking red flags should prompt earlier bone ...
Contemporary OB/GYN

Perimenopause and mental health: Beyond hormonal vs psychological

Anxiety, brain fog, and mood changes in midlife patients warranted validation and a structured evaluation that considered ...
Contemporary OB/GYN

Garima Sharma, MD, on cardio-obstetrics framework, cardiovascular risk

Sharma said the team-based model should flag patients with multiple cardiovascular risk factors—hypertension, diabetes, high cholesterol, obesity, arrhythmias, or established disease such as heart ...
Contemporary OB/GYN

Sarah W. Prager, MD, MAs

A review finds post-miscarriage ultrasound heterogeneity is common and that symptoms, not endometrial thickness, should guide management after EPL.
Contemporary OB/GYN

Actigraphy supports fezolinetant sleep improvements by week 4

Objective sleep data captured by actigraphy in the phase 4 OPTION-VMS study corroborated patient-reported sleep improvements with fezolinetant (Veozah), according to Marla Shapiro ...